Your browser doesn't support javascript.
loading
Post primary percutaneous coronary intervention no-reflow in patients with acute myocardial infarction: contributing factors and long-term prognostic impact / 中华心血管病杂志
Zhonghua xinxueguanbing zazhi ; (12): 483-486, 2006.
Article in Zh | WPRIM | ID: wpr-295291
Responsible library: WPRO
ABSTRACT
<p><b>OBJECTIVE</b>To elucidate the relative factors and prognostic impact for angiographic no-reflow phenomenon during primary percutaneous coronary intervention (PCI) in patients with acute myocardial infarction (AMI).</p><p><b>METHODS</b>A total of 930 patients with AMI who underwent primary PCI were divided into no-reflow group and normal-reflow group. Factors related to no-reflow were analyzed by logistic regression model and major adverse cardiac events (MACE) in-hospital as well as during long-term follow-up was also observed.</p><p><b>RESULTS</b>No-reflow occurred in 82 out of 930 patients. Admission glucose level (9.8 +/- 4.3 mmol/L vs. 8.5 +/- 3.5 mmol/L, P = 0.001), peak CK-MB value (369.4 +/- 167.8 U/L vs. 282.3 +/- 161.7 U/L, P < 0.01) and percentage of TIMI flow grade 0 on initial angiogram (69.5% vs. 54.5%, P = 0.009) were significantly higher and pre-infarction angina (19.5% vs. 48.1%, P < 0.01) was significantly lower in no-flow patients than normal flow patients. Logistic regression analyses showed that admission glucose level, absence of pre-infarction angina, TIMI flow grade 0 on initial angiogram and pump failure were independent predictors of no reflow. In-hospital MACE (37.8% vs. 11.3%, P < 0.01) and follow-up MACE (37.5% vs. 17.4%, P < 0.01) were also significantly higher in no-flow patients than normal flow patients. Multivariate Cox regression analysis revealed that no-reflow was an independent predictor of long-term cardiac death (relative risk 3.83, 95% confidence interval 1.71 to 5.57).</p><p><b>CONCLUSION</b>Admission glucose level, absence of pre-infarction angina, TIMI flow grade 0 on initial angiogram and pump failure were independent risk factors for no-reflow and no-flow is an independent predictor for increased in-hospital and follow-up MACE.</p>
Subject(s)
Full text: 1 Index: WPRIM Main subject: Prognosis / Therapeutics / Blood Glucose / Angioplasty, Balloon, Coronary / Follow-Up Studies / Treatment Outcome / Diagnosis / Angina Pectoris / Myocardial Infarction Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male Language: Zh Journal: Zhonghua xinxueguanbing zazhi Year: 2006 Type: Article
Full text: 1 Index: WPRIM Main subject: Prognosis / Therapeutics / Blood Glucose / Angioplasty, Balloon, Coronary / Follow-Up Studies / Treatment Outcome / Diagnosis / Angina Pectoris / Myocardial Infarction Type of study: Diagnostic_studies / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Humans / Male Language: Zh Journal: Zhonghua xinxueguanbing zazhi Year: 2006 Type: Article